Search research articles
Contact Us
Filters
Showing results (1-10 of 96) with videos related to
Page
of 10
Sort By:
Progress in Molecular Biology and Translational Science
|
November 19, 2017
CRISPR Libraries and Screening
John T Poirier
Nature Reviews. Clinical Oncology
|
December 14, 2016
Small-cell lung cancer in 2016: Shining light on novel targets and therapies
Charles M Rudin, John T Poirier
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 28, 2017
Histone Code Aberrancies in Small Cell Lung Cancer
Eric E Gardner, John T Poirier, Charles M Rudin
The FEBS Journal
|
June 3, 2016
Design, execution, and analysis of pooled in vitro CRISPR/Cas9 screens
Linde A Miles, Ralph J Garippa, John T Poirier
Oncolytic Virotherapy
|
March 19, 2020
Virus-Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development
Nadishka Jayawardena, John T Poirier, Laura N Burga, et al.
Journal of Lipid Research
|
August 5, 2022
Generation of hepatoma cell lines deficient in microsomal triglyceride transfer protein
Narasimha Anaganti, Atrayee Chattopadhyay, John T Poirier, et al.
Oncolytic Virotherapy
|
November 23, 2019
Virus-Receptor Interactions: Structural Insights For Oncolytic Virus Development
Nadishka Jayawardena, Laura N Burga, John T Poirier, et al.
Plos One
|
June 13, 2015
Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for Use in Peptide-Prodrug Therapy
Linde A Miles, W Nathaniel Brennen, Charles M Rudin, et al.
Plos One
|
August 20, 2015
Correction: Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for use in Peptide-Prodrug Therapy
Linde A Miles, W Nathaniel Brennen, Charles M Rudin, et al.
Molecular Cancer Therapeutics
|
August 19, 2007
Rapamycin inhibits multiple stages of c-Neu/ErbB2 induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Jonathan D Mosley, John T Poirier, Darcie D Seachrist, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 96) with videos related to
Sort By:
Page
of 10
Progress in Molecular Biology and Translational Science
|
November 19, 2017
CRISPR Libraries and Screening
John T Poirier
Nature Reviews. Clinical Oncology
|
December 14, 2016
Small-cell lung cancer in 2016: Shining light on novel targets and therapies
Charles M Rudin, John T Poirier
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 28, 2017
Histone Code Aberrancies in Small Cell Lung Cancer
Eric E Gardner, John T Poirier, Charles M Rudin
The FEBS Journal
|
June 3, 2016
Design, execution, and analysis of pooled in vitro CRISPR/Cas9 screens
Linde A Miles, Ralph J Garippa, John T Poirier
Oncolytic Virotherapy
|
March 19, 2020
Virus-Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development
Nadishka Jayawardena, John T Poirier, Laura N Burga, et al.
Journal of Lipid Research
|
August 5, 2022
Generation of hepatoma cell lines deficient in microsomal triglyceride transfer protein
Narasimha Anaganti, Atrayee Chattopadhyay, John T Poirier, et al.
Oncolytic Virotherapy
|
November 23, 2019
Virus-Receptor Interactions: Structural Insights For Oncolytic Virus Development
Nadishka Jayawardena, Laura N Burga, John T Poirier, et al.
Plos One
|
June 13, 2015
Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for Use in Peptide-Prodrug Therapy
Linde A Miles, W Nathaniel Brennen, Charles M Rudin, et al.
Plos One
|
August 20, 2015
Correction: Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for use in Peptide-Prodrug Therapy
Linde A Miles, W Nathaniel Brennen, Charles M Rudin, et al.
Molecular Cancer Therapeutics
|
August 19, 2007
Rapamycin inhibits multiple stages of c-Neu/ErbB2 induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Jonathan D Mosley, John T Poirier, Darcie D Seachrist, et al.
Page
of 10